HC-030031

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

HC-030031

CAS No. : 349085-38-7

MCE 国际站：HC-030031

产品活性：HC-030031 是一种有效的选择性的 TRPA1 抑制剂，拮抗 AITC 和福尔马林诱发的钙流入，IC₅₀ 分别为 6.2±0.2 和 5.3±0.2 μM。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling

作用靶点：TRP Channel

In Vitro: HC-030031 reversibly blocks TRPA1 currents with a similar potency, regardless of the agonist used; this includes blockade of currents elicited by reversible agonists, such as AITC, or irreversible agonists, such as N-methyl maleimide. HC-030031 blocks activation of TRPA1 by N-methyl maleimide, which opens the channel irreversibly through cysteine modification. HC-030031 does not block currents mediated by TRPV1, TRPV3, TRPV4, hERG, or NaV1.2 channels. The potencies of HC-030031 versus cinnamaldehyde or allyl isothiocyanate (AITC or Mustard oil)-induced TRPA1 activation are 4.9±0.1 and 7.5±0.2 μM respectively (IC₅₀). These findings are similar to the previously reported IC₅₀ of 6.2 μM against AITC activation of TRPA1. The ability of HC-030031 to block TRPA1 activation is tested in a FLIPR calcium-influx assay using HEK-293 cells stably expressing human TRPA1. Concentrations of HC-030031 from 0.3 to 60 μM are incubated with cells for 10 minutes prior to addition of an EC₆₀ concentration of either cinnamaldehyde or AITC. HC-030031 dose-dependently blocks cinnamaldehyde- and AITC-induced calcium influx with IC₅₀ values of 4.9 and 7.5 μM, respectively.

In Vivo: After injection of AITC (50 μL of 10%) into the rat hind paw, HC-030031 (300 mg/kg) significantly reduces flinching during the first 5 min. Over the remainder of the hour, HC-030031 decreases flinch frequency, a result that mirrors the effects observed on formalin-induced flinching. In the rat, oral administration of HC-030031 reduces AITC-induced nocifensive behaviors at a dose of 100 mg/kg. Moreover, oral HC-030031 (100 mg/kg) significantly reverses mechanical hypersensitivity in the more chronic models of Complete Freunds Adjuvant (CFA)-induced inflammatory pain and the spinal nerve ligation model of neuropathic pain. One hour post-oral administration, HC-030031 significantly reduces the lifting duration following 1% AITC injection (p<0.001). HC-030031 completely reverses the enhanced mechanical firing in inflamed mice (p<0.001).

相关产品：Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Neuronal Signaling Compound Library  |  Mechanoreceptors Compound Library  |  Human Metabolite Library  |  Pain-Related Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Ion Channel Compound Library  |  Rosiglitazone  |  Capsaicin  |  GsMTx4  |  EIPA  |  Probenecid  |  Diphenyleneiodonium chloride  |  2-Aminoethyl diphenylborinate  |  Amiloride hydrochloride  |  GSK1016790A  |  Capsazepine  |  HC-067047  |  ML-SA1  |  GSK2193874  |  Adenosine 5′-diphosphoribose sodium  |  AMG9810  |  GSK205  |  SKF-96365 hydrochloride  |  (-)-Menthol  |  Caffeic acid  |  ML-SI1  |  BI-749327  |  GSK2798745  |  Pregnenolone  |  ML-SA5  |  N-(p-amylcinnamoyl) Anthranilic Acid  |  A-967079  |  MK6-83  |  Pico145  |  SAR7334

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds